A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
Clinical trial NCT06699212 · RECRUITING
Trial details
- NCT number
- NCT06699212
- Sponsor
- Rakuten Medical, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-24
- Primary completion
- 2028-09-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.